Circulating Tumor Cells-Global Market Status and Trend Report 2014-2026

Publisher Name :
Date: 01-Aug-2019
No. of pages: 144

Report Summary

Circulating Tumor Cells-Global Market Status and Trend Report 2014-2026 offers a comprehensive analysis on Circulating Tumor Cells industry, standing on the readers' perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Circulating Tumor Cells 2014-2019, and development forecast 2020-2026

Main manufacturers/suppliers of Circulating Tumor Cells worldwide, with company and product introduction, position in the Circulating Tumor Cells market

Market status and development trend of Circulating Tumor Cells by types and applications

Cost and profit status of Circulating Tumor Cells, and marketing status

Market growth drivers and challenges

The report segments the global Circulating Tumor Cells market as:

Global Circulating Tumor Cells Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2014-2026):

North America

Europe

China

Japan

Rest APAC

Latin America

Global Circulating Tumor Cells Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2014-2026):

CTC enrichment

CTC detection

CTC analysis

Global Circulating Tumor Cells Market: Application Segment Analysis (Consumption Volume and Market Share 2014-2026; Downstream Customers and Market Analysis)

Prostate Cancer

Breast Cancer

Colorectal Cancer

Others

Global Circulating Tumor Cells Market: Manufacturers Segment Analysis (Company and Product introduction, Circulating Tumor Cells Sales Volume, Revenue, Price and Gross Margin):

Janssen

Qiagen(Adnagen)

Acousys Biodevices

ApoCell

Advanced Cell Diagnostics

Fluxion Biosciences

Biocept

Fluidigm

Epic Sciences

Clearbridge Biomedics

Cynvenio

CytoTrack

ScreenCell

Creatv Microtech

Aviva Biosciences

Greiner Bio-one GmbH

Sysmex Corporation

Ikonisys

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Circulating Tumor Cells-Global Market Status and Trend Report 2014-2026

Table of Contents

Chapter 1 Overview of Circulating Tumor Cells
1.1 Definition of Circulating Tumor Cells in This Report
1.2 Commercial Types of Circulating Tumor Cells
1.2.1 CTC enrichment
1.2.2 CTC detection
1.2.3 CTC analysis
1.3 Downstream Application of Circulating Tumor Cells
1.3.1 Prostate Cancer
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Others
1.4 Development History of Circulating Tumor Cells
1.5 Market Status and Trend of Circulating Tumor Cells 2014-2026
1.5.1 Global Circulating Tumor Cells Market Status and Trend 2014-2026
1.5.2 Regional Circulating Tumor Cells Market Status and Trend 2014-2026

Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Circulating Tumor Cells 2014-2019
2.2 Production Market of Circulating Tumor Cells by Regions
2.2.1 Production Volume of Circulating Tumor Cells by Regions
2.2.2 Production Value of Circulating Tumor Cells by Regions
2.3 Demand Market of Circulating Tumor Cells by Regions
2.4 Production and Demand Status of Circulating Tumor Cells by Regions
2.4.1 Production and Demand Status of Circulating Tumor Cells by Regions 2014-2019
2.4.2 Import and Export Status of Circulating Tumor Cells by Regions 2014-2019

Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Circulating Tumor Cells by Types
3.2 Production Value of Circulating Tumor Cells by Types
3.3 Market Forecast of Circulating Tumor Cells by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Circulating Tumor Cells by Downstream Industry
4.2 Market Forecast of Circulating Tumor Cells by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Circulating Tumor Cells
5.1 Global Economy Situation and Trend Overview
5.2 Circulating Tumor Cells Downstream Industry Situation and Trend Overview

Chapter 6 Circulating Tumor Cells Market Competition Status by Major Manufacturers
6.1 Production Volume of Circulating Tumor Cells by Major Manufacturers
6.2 Production Value of Circulating Tumor Cells by Major Manufacturers
6.3 Basic Information of Circulating Tumor Cells by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Circulating Tumor Cells Major Manufacturer
6.3.2 Employees and Revenue Level of Circulating Tumor Cells Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch

Chapter 7 Circulating Tumor Cells Major Manufacturers Introduction and Market Data
7.1 Janssen
7.1.1 Company profile
7.1.2 Representative Circulating Tumor Cells Product
7.1.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Janssen
7.2 Qiagen(Adnagen)
7.2.1 Company profile
7.2.2 Representative Circulating Tumor Cells Product
7.2.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Qiagen(Adnagen)
7.3 Acousys Biodevices
7.3.1 Company profile
7.3.2 Representative Circulating Tumor Cells Product
7.3.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Acousys Biodevices
7.4 ApoCell
7.4.1 Company profile
7.4.2 Representative Circulating Tumor Cells Product
7.4.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of ApoCell
7.5 Advanced Cell Diagnostics
7.5.1 Company profile
7.5.2 Representative Circulating Tumor Cells Product
7.5.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Advanced Cell Diagnostics
7.6 Fluxion Biosciences
7.6.1 Company profile
7.6.2 Representative Circulating Tumor Cells Product
7.6.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Fluxion Biosciences
7.7 Biocept
7.7.1 Company profile
7.7.2 Representative Circulating Tumor Cells Product
7.7.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Biocept
7.8 Fluidigm
7.8.1 Company profile
7.8.2 Representative Circulating Tumor Cells Product
7.8.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Fluidigm
7.9 Epic Sciences
7.9.1 Company profile
7.9.2 Representative Circulating Tumor Cells Product
7.9.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Epic Sciences
7.10 Clearbridge Biomedics
7.10.1 Company profile
7.10.2 Representative Circulating Tumor Cells Product
7.10.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Clearbridge Biomedics
7.11 Cynvenio
7.11.1 Company profile
7.11.2 Representative Circulating Tumor Cells Product
7.11.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Cynvenio
7.12 CytoTrack
7.12.1 Company profile
7.12.2 Representative Circulating Tumor Cells Product
7.12.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of CytoTrack
7.13 ScreenCell
7.13.1 Company profile
7.13.2 Representative Circulating Tumor Cells Product
7.13.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of ScreenCell
7.14 Creatv Microtech
7.14.1 Company profile
7.14.2 Representative Circulating Tumor Cells Product
7.14.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Creatv Microtech
7.15 Aviva Biosciences
7.15.1 Company profile
7.15.2 Representative Circulating Tumor Cells Product
7.15.3 Circulating Tumor Cells Sales, Revenue, Price and Gross Margin of Aviva Biosciences
7.16 Greiner Bio-one GmbH
7.17 Sysmex Corporation
7.18 Ikonisys

Chapter 8 Upstream and Downstream Market Analysis of Circulating Tumor Cells
8.1 Industry Chain of Circulating Tumor Cells
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Circulating Tumor Cells
9.1 Cost Structure Analysis of Circulating Tumor Cells
9.2 Raw Materials Cost Analysis of Circulating Tumor Cells
9.3 Labor Cost Analysis of Circulating Tumor Cells
9.4 Manufacturing Expenses Analysis of Circulating Tumor Cells

Chapter 10 Marketing Status Analysis of Circulating Tumor Cells
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs